A Multicentre, Open Label, Observational 24-Week Study to Evaluate Safety of Initiating Insulin Therapy With Levemir (Insulin Detemir) Once-Daily in Oral Antidiabetic Drug-Treated Patients With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms SOLVE
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 01 Mar 2016 Results (n=17374) of patient subgroup analysis were published in the International Journal of Clinical Practice.
- 28 Jun 2011 Acutal patient number (n=12,989) reported at 71st Scientific Sessions of the America Diabetes Association